JP2021501589A5 - - Google Patents

Download PDF

Info

Publication number
JP2021501589A5
JP2021501589A5 JP2020524434A JP2020524434A JP2021501589A5 JP 2021501589 A5 JP2021501589 A5 JP 2021501589A5 JP 2020524434 A JP2020524434 A JP 2020524434A JP 2020524434 A JP2020524434 A JP 2020524434A JP 2021501589 A5 JP2021501589 A5 JP 2021501589A5
Authority
JP
Japan
Prior art keywords
antigen recognition
recognition construct
construct
host cell
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020524434A
Other languages
English (en)
Japanese (ja)
Other versions
JP7510873B2 (ja
JP2021501589A (ja
Filing date
Publication date
Priority claimed from DE102017125888.4A external-priority patent/DE102017125888A1/de
Application filed filed Critical
Priority claimed from PCT/EP2018/080176 external-priority patent/WO2019086665A1/en
Publication of JP2021501589A publication Critical patent/JP2021501589A/ja
Publication of JP2021501589A5 publication Critical patent/JP2021501589A5/ja
Priority to JP2024101016A priority Critical patent/JP2024156654A/ja
Application granted granted Critical
Publication of JP7510873B2 publication Critical patent/JP7510873B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020524434A 2017-11-06 2018-11-05 新規操作t細胞受容体およびそれを使用した免疫療法 Active JP7510873B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024101016A JP2024156654A (ja) 2017-11-06 2024-06-24 新規操作t細胞受容体およびそれを使用した免疫療法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762582202P 2017-11-06 2017-11-06
DE102017125888.4 2017-11-06
US62/582,202 2017-11-06
DE102017125888.4A DE102017125888A1 (de) 2017-11-06 2017-11-06 Neue konstruierte T-Zell-Rezeptoren und deren Verwendung in Immuntherapie
PCT/EP2018/080176 WO2019086665A1 (en) 2017-11-06 2018-11-05 Novel engineered t cell receptors and immune therapy using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024101016A Division JP2024156654A (ja) 2017-11-06 2024-06-24 新規操作t細胞受容体およびそれを使用した免疫療法

Publications (3)

Publication Number Publication Date
JP2021501589A JP2021501589A (ja) 2021-01-21
JP2021501589A5 true JP2021501589A5 (cg-RX-API-DMAC7.html) 2021-12-16
JP7510873B2 JP7510873B2 (ja) 2024-07-04

Family

ID=66336165

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020524434A Active JP7510873B2 (ja) 2017-11-06 2018-11-05 新規操作t細胞受容体およびそれを使用した免疫療法

Country Status (12)

Country Link
EP (1) EP3707159B1 (cg-RX-API-DMAC7.html)
JP (1) JP7510873B2 (cg-RX-API-DMAC7.html)
KR (1) KR102793492B1 (cg-RX-API-DMAC7.html)
CN (1) CN111448209B (cg-RX-API-DMAC7.html)
AR (1) AR113834A1 (cg-RX-API-DMAC7.html)
AU (1) AU2018358085B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020008943A2 (cg-RX-API-DMAC7.html)
CA (1) CA3081780A1 (cg-RX-API-DMAC7.html)
DE (1) DE102017125888A1 (cg-RX-API-DMAC7.html)
MA (1) MA50562A (cg-RX-API-DMAC7.html)
PE (1) PE20211452A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202003404UA (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102020111571A1 (de) * 2020-03-11 2021-09-16 Immatics US, Inc. Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren
CN120718134B (zh) * 2025-08-25 2025-12-26 北京立康生命科技有限公司 靶向col6a3肽的t细胞受体及其用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2246502T3 (es) 1990-08-29 2006-02-16 Genpharm International, Inc. Animales no humanos transgenicos capaces de producir anticuerpos heterologos.
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5714352A (en) 1996-03-20 1998-02-03 Xenotech Incorporated Directed switch-mediated DNA recombination
WO2001058479A1 (en) 2000-02-08 2001-08-16 The Penn State Research Foundation Immunotherapy using interleukin 13 receptor subunit alpha 2
WO2006023382A2 (en) * 2004-08-23 2006-03-02 Albert Einstein College Of Medicine Of Yeshiva University Collagen vi and cancer
GB201004551D0 (en) * 2010-03-19 2010-05-05 Immatics Biotechnologies Gmbh NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer
US10738278B2 (en) 2014-07-15 2020-08-11 Juno Therapeutics, Inc. Engineered cells for adoptive cell therapy
GB201505305D0 (en) * 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
DE102016115246C5 (de) 2016-08-17 2018-12-20 Immatics Biotechnologies Gmbh Neue t-zellrezeptoren und deren verwendung in immuntherapie
DE102016121899A1 (de) 2016-11-15 2018-05-17 Immatics Biotechnologies Gmbh Verfahren zur Herstellung von elektrokompetenten Hefezellen und Verfahren zur Verwendung dieser Zellen
DE102016123893A1 (de) 2016-12-08 2018-06-14 Immatics Biotechnologies Gmbh T-Zellrezeptoren mit verbesserter Bindung

Similar Documents

Publication Publication Date Title
JP7526121B2 (ja) キメラ抗原受容体を使用する癌の処置
JP2020500523A5 (cg-RX-API-DMAC7.html)
JP2020529830A5 (cg-RX-API-DMAC7.html)
JP2020511152A5 (cg-RX-API-DMAC7.html)
FI3707159T3 (fi) Uusia muokattuja t-solureseptoreita ja niitä käyttävä immuuniterapia
AU2014228962B2 (en) Multimerization technologies
HRP20241228T1 (hr) T stanični receptori i imunološka terapija uporabom istih protiv pram pozitivnih karcinoma
JP2020096630A5 (cg-RX-API-DMAC7.html)
US20170274014A1 (en) Combinations of low, immune enhancing, doses of mtor inhibitors and cars
US20180334490A1 (en) Methods for b cell preconditioning in car therapy
AU2019256431A1 (en) Anti-ror antibody constructs
HRP20220131T1 (hr) Nova terapija s t-staničnim receptorima i imunološka terapija koja koristi iste
CN110835371A (zh) 抗ccr8单克隆抗体及其应用
JP2019511222A5 (cg-RX-API-DMAC7.html)
JP2020500510A5 (cg-RX-API-DMAC7.html)
FI3430030T3 (fi) Transfektoituja t-soluja ja t-solureseptoreita käytettäviksi syöpien immunoterapiassa
JP2018166506A5 (cg-RX-API-DMAC7.html)
JP2017528433A (ja) 低い免疫増強用量のmTOR阻害剤とCARの組み合わせ
CA2931684A1 (en) Human mesothelin chimeric antigen receptors and uses thereof
TW202033557A (zh) 特異性結合至人類T細胞受體之TRBV-9家族之β區的單株抗體及其使用之方法
CN116249769A (zh) 功能增强的免疫细胞
CN117186229B (zh) 具有长cdr3序列的抗人bcma纳米抗体及car-t和应用
US20250276064A1 (en) Engineered chimeric fusion protein compositions and methods of use thereof
CN117069842B (zh) 具有特定等电点的抗人bcma纳米抗体及car-t和应用
CN116997572A (zh) 小细胞肺癌的分类与治疗的方法和系统